Results 161 to 170 of about 222,329 (311)
A Vanishing Lung Tumor in Congestive Heart Failure. [PDF]
David R, Edwin G, Alphonce B, Kusima H.
europepmc +1 more source
The design of the mortality assessment in congestive heart failure trial (MACH‐1, Mibefradil) [PDF]
T. Barry Levine
openalex +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
Abstract Neonatal acute liver failure (ALF) carries a high mortality rate; however, little data exist on its peritransplant hospital course. This project aimed to identify factors associated with outcomes in neonates with ALF using large multicenter databases.
Swati Antala +6 more
wiley +1 more source
Severe Cardiomegaly in Congestive Heart Failure: Postmortem Evidence of Cardiac Remodeling. [PDF]
Mote TR +3 more
europepmc +1 more source
Decreased hematopoiesis in bone marrow of mice with congestive heart failure [PDF]
Per Ole Iversen +3 more
openalex +1 more source
Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén +16 more
wiley +1 more source
Reversible congestive heart failure associated with diabetes mellitus in two cats. [PDF]
Cho J +6 more
europepmc +1 more source
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu +9 more
wiley +1 more source

